Kenneth Wong, Keen Vision Acquisition chairman and CEO
February 10, 2023 11:10 AM EST
Financing

New SPAC sub­mits plans for $130M IPO, as an­oth­er rais­es $60M

Paul Schloesser

Associate Editor

Two new biotech SPACs have come to town — and one of them has gone pub­lic.

Keen Vi­sion Ac­qui­si­tion Corp. an­nounced its for­ma­tion via SEC fil­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Q&A: Demis Has­s­abis talks win­ning the No­bel Prize, build­ing an AI biotech sans lab, and Trump’s po­ten­tial im­pact

Avid Bioser­vices to be sold to pri­vate eq­ui­ty firms for $1.1B

Biotech in­dus­try wor­ries over po­ten­tial for RFK Jr. al­ly as FDA pick

De­nali teas­es ear­ly da­ta for en­zyme re­place­ment ther­a­py in rare dis­ease

Gen­mab chops ear­ly can­cer prospects to pri­or­i­tize Phase 3 projects

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times